IFNG and cancer: On the other hand, IFN-γ acts in a negative-feedback axis to elevate PD-L1 expression as well as other crucial immune inhibitory components, including IDO1, down-modulating the cytotoxic reaction and adaptive resistance to cancer cells (80, 81) (Figure 1A).